Amgen Business Development
Overview
Amgen Business Development is the corporate venture capital arm of Amgen Inc., focusing on investments in biotechnology and life sciences companies. The team brings together deep scientific, financial, deal, partnership, and integration expertise to identify and support innovative companies that align with Amgen's strategic interests. Their investments aim to advance Amgen's mission of delivering innovative medicines to patients worldwide. The investment strategy encompasses a broad range of stages, from early-stage startups to more mature companies, with investment sizes typically ranging from $5 million to $50 million. Geographically, Amgen Business Development targets regions including the United States, Europe, Asia, Australia, Canada, Japan, South Korea, China, India, Brazil, Mexico, Argentina, Chile, Colombia, Peru, South Africa, Egypt, Saudi Arabia, United Arab Emirates, and Israel. Industries of interest include biotechnology, pharmaceuticals, healthcare, medical devices, diagnostics, digital health, genomics, immunology, oncology, cardiovascular, neuroscience, rare diseases, regenerative medicine, cell therapy, and gene therapy. This diverse focus reflects Amgen's commitment to advancing science and improving patient outcomes across a wide array of therapeutic areas.
Investment Focus
- Innovative technologies
- Strong scientific evidence
- Alignment with Amgen's strategic interests
- Experienced management teams
- Scalable business models
- Potential for significant patient impact
Portfolio Companies
Get the full list of 54,000+ investors
Amgen Business Development and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Amgen Business Development
What sectors does Amgen Business Development invest in?
Amgen Business Development invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in California, United States. Amgen Business Development is listed as a corporate vc in the ConnectSafely investor database.
What stage does Amgen Business Development invest at?
Amgen Business Development backs companies at Early Stage, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Amgen Business Development invest in?
Amgen Business Development invests across United States, Canada, Japan, Australia, Europe and Asia.
What companies has Amgen Business Development invested in?
Amgen Business Development's portfolio includes BeiGene, Five Prime Therapeutics, Rodeo Therapeutics, Teneobio, Neumora Therapeutics, Generate Biomedicines, Arrakis Therapeutics and Plexium.
Last updated · Source: ConnectSafely investor database